CMP Pharma Inc – FDA 483, Jun 26, 2018
An FDA inspection of CMP Pharma Inc, a manufacturer in Farmville, NC, revealed significant deficiencies in their quality control unit and investigation procedures. The firm failed to complete required annual product reviews and lacked proper Quality/Supplier Agreements for contract laboratories. Additionally, their written investigation records were inadequate, with CAPA procedures missing effectiveness checks and deviation procedures lacking instructions for root cause analysis and historical reviews.
ID · 2927d0d9-9a84-42dc-9147-5158673f4bdf
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.